Experimental Adjustment on Drug Interactions through Intestinal CYP3A Activity in Rat: Impacts of Kampo Medicines Repeat Administered
2011

Effects of Kampo Medicines on Drug Metabolism in Rats

Sample size: 4 publication 10 minutes Evidence: moderate

Author Information

Author(s): Natsumi Kinoshita, Yuriko Yamaguchi, Hou Xiao-Long, Kyoko Takahashi, Koichi Takahashi

Primary Institution: Mukogawa Women's University

Hypothesis

How do kampo medicines Saireito and Hochuekkito affect the metabolism of nifedipine in rats?

Conclusion

Saireito and Hochuekkito significantly alter the pharmacokinetics of nifedipine by increasing intestinal CYP3A activity.

Supporting Evidence

  • Oral pre-treatment with Saireito led to a significant decrease in the Cmax of nifedipine.
  • Saireito increased CYP3A protein expression in the small intestine but not in the liver.
  • The pharmacokinetics of nifedipine were unaffected by intravenous administration after kampo treatment.

Takeaway

This study shows that certain traditional Japanese medicines can change how a drug is processed in the body, which might make the drug less effective.

Methodology

The study involved administering kampo medicines to rats and measuring the pharmacokinetics of nifedipine through various methods including HPLC analysis.

Potential Biases

Potential bias due to the specific strains of rats used and the controlled laboratory conditions.

Limitations

The study was conducted on rats, and the effects may not directly translate to humans.

Participant Demographics

Male Wistar/ST rats, weighing 220–290 g.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1093/ecam/nep159

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication